• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FIDIA FARMACEUTICI S.P.A. HYALGAN; SODIUM HYALURONATE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FIDIA FARMACEUTICI S.P.A. HYALGAN; SODIUM HYALURONATE Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Malaise (2359); Respiratory Arrest (4461); Reaction to Medicinal Component of Device (4574)
Event Date 07/16/2021
Event Type  Injury  
Event Description
A (b)(6) year-old female patient used 1 dose of hyalgan (hyaluronate sodium) via intra-articular route, for osteoarthritis, on (b)(6) 2021 and diprostene (betamethasone dipropionate; betamethasone sodium phosphate) unknown pharmaceutical form, at unknown dose, for unknown indication.On the same date, the patient experienced malaise and respiratory arrest.At the time of the reporting, the outcome was resolved.Reaction as described by the primary source: after the injection of a corticosteroid (diprostene) + hyalgan, the patient presented with malaise followed by respiratory arrest.Concomitant medication: algicare (anti-inflammatory food supplement); algesic plus (paracetamol+codeine); aléogine (a harpagophytum-based gel) medical history: asthmatic patient.No further information is available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HYALGAN
Type of Device
SODIUM HYALURONATE
Manufacturer (Section D)
FIDIA FARMACEUTICI S.P.A.
via ponte della fabbrica 3/a
abano terme, 35031
IT  35031
Manufacturer (Section G)
FIDIA FARMACEUTICI S.P.A.
via ponte della fabbrica 3/a
abano terme, padua 35031
IT   35031
Manufacturer Contact
giuseppe di sante
via ponte della fabbrica 3/a
abano terme, padua 35031
IT   35031
MDR Report Key12834274
MDR Text Key280933625
Report Number9610200-2021-00004
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeTS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 11/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/18/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/19/2021
Was Device Evaluated by Manufacturer? No
Is This a Reprocessed and Reused Single-Use Device? Yes
Type of Device Usage Initial
Patient Sequence Number1
Treatment
DIPROSTENEALGESIC PLUS
Patient Outcome(s) Hospitalization;
Patient Age78 YR
Patient SexFemale
-
-